Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by PADMANEE SHARMA and WILLEM OVERWIJK.
PADMANEE SHARMA
Connection Strength
0.335
WILLEM OVERWIJK
  1. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018 04 02; 128(4):1338-1354.
    View in: PubMed
    Score: 0.157
  2. Harnessing the power of the immune system to target cancer. Annu Rev Med. 2013; 64:71-90.
    View in: PubMed
    Score: 0.108
  3. Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. Cancer Res. 2017 02 15; 77(4):839-850.
    View in: PubMed
    Score: 0.036
  4. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov. 2016 08; 6(8):827-37.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.